Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease

Daisuke Hachinohe, Myung Ho Jeong, Shigeru Saito, Min Chol Kim, Kyung Hoon Cho, Khurshid Ahmed, Seung Hwan Hwang, Min Goo Lee, Doo Sun Sim, Keun Ho Park, Ju Han Kim, Young Joon Hong, Youngkeun Ahn, Jung Chaee Kang, Jong Hyun Kim, Shung Chull Chae, Young Jo Kim, Seung Ho Hur, In Whan Seong, Taek Jong Hong & 9 others Donghoon Choi, Myeong Chan Cho, Chong Jin Kim, Ki Bae Seung, Wook Sung Chung, Yang Soo Jang, Seung-Woon Rha, Jang Ho Bae, Seung Jung Park

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aims: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI) patients with chronic kidney disease (CKD). Methods: This study included a total of 3,566 acute MI survivors with CKD from the Korea Acute Myocardial Infarction Registry who were treated with stenting and followed up for 12 months: 1,845 patients who received sirolimus-eluting stents (SES), 1,356 who received paclitaxel-eluting stents (PES), and 365 who received zotarolimus-eluting stents (ZES). CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m2 calculated by the modification of diet in renal disease method. Results: At the 12-month follow-up, patients receiving ZES demonstrated a higher incidence (14.8%) of major adverse cardiac events (MACEs) compared to those receiving SES (10.1%) and PES (12%, p = 0.019). The ZES patients also had a higher incidence (3.9%) of target lesion revascularization (TLR) compared to those receiving SES (1.5%) and PES (2.4%, p = 0.011). After adjusting for confounding factors, ZES was associated with a higher incidence of MACE and TLR than SES (adjusted hazard ratio [HR], 0.623; 95% confidence interval [CI], 0.442 to 0.879; p = 0.007; adjusted HR, 0.350; 95% CI, 0.165 to 0.743; p = 0.006, respectively), and with a higher rate of TLR than PES (adjusted HR, 0.471; 95% CI, 0.223 to 0.997; p = 0.049). Conclusions: Our findings suggest that ZES is less effective than SES and PES in terms of 12-month TLR, and has a higher incidence of MACE due to a higher TLR rate compared with SES, in acute MI patients with CKD.

Original languageEnglish
Pages (from-to)397-406
Number of pages10
JournalKorean Journal of Internal Medicine
Volume27
Issue number4
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Drug-Eluting Stents
Chronic Renal Insufficiency
Stents
Myocardial Infarction
Sirolimus
Paclitaxel
Incidence
Confidence Intervals
Diet Therapy
Korea
Glomerular Filtration Rate

Keywords

  • Chronic
  • Myocardial infarction
  • Renal insufficiency
  • Stents

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hachinohe, D., Jeong, M. H., Saito, S., Kim, M. C., Cho, K. H., Ahmed, K., ... Park, S. J. (2012). Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease. Korean Journal of Internal Medicine, 27(4), 397-406. https://doi.org/10.3904/kjim.2012.27.4.397

Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease. / Hachinohe, Daisuke; Jeong, Myung Ho; Saito, Shigeru; Kim, Min Chol; Cho, Kyung Hoon; Ahmed, Khurshid; Hwang, Seung Hwan; Lee, Min Goo; Sim, Doo Sun; Park, Keun Ho; Kim, Ju Han; Hong, Young Joon; Ahn, Youngkeun; Kang, Jung Chaee; Kim, Jong Hyun; Chae, Shung Chull; Kim, Young Jo; Hur, Seung Ho; Seong, In Whan; Hong, Taek Jong; Choi, Donghoon; Cho, Myeong Chan; Kim, Chong Jin; Seung, Ki Bae; Chung, Wook Sung; Jang, Yang Soo; Rha, Seung-Woon; Bae, Jang Ho; Park, Seung Jung.

In: Korean Journal of Internal Medicine, Vol. 27, No. 4, 01.12.2012, p. 397-406.

Research output: Contribution to journalArticle

Hachinohe, D, Jeong, MH, Saito, S, Kim, MC, Cho, KH, Ahmed, K, Hwang, SH, Lee, MG, Sim, DS, Park, KH, Kim, JH, Hong, YJ, Ahn, Y, Kang, JC, Kim, JH, Chae, SC, Kim, YJ, Hur, SH, Seong, IW, Hong, TJ, Choi, D, Cho, MC, Kim, CJ, Seung, KB, Chung, WS, Jang, YS, Rha, S-W, Bae, JH & Park, SJ 2012, 'Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease', Korean Journal of Internal Medicine, vol. 27, no. 4, pp. 397-406. https://doi.org/10.3904/kjim.2012.27.4.397
Hachinohe, Daisuke ; Jeong, Myung Ho ; Saito, Shigeru ; Kim, Min Chol ; Cho, Kyung Hoon ; Ahmed, Khurshid ; Hwang, Seung Hwan ; Lee, Min Goo ; Sim, Doo Sun ; Park, Keun Ho ; Kim, Ju Han ; Hong, Young Joon ; Ahn, Youngkeun ; Kang, Jung Chaee ; Kim, Jong Hyun ; Chae, Shung Chull ; Kim, Young Jo ; Hur, Seung Ho ; Seong, In Whan ; Hong, Taek Jong ; Choi, Donghoon ; Cho, Myeong Chan ; Kim, Chong Jin ; Seung, Ki Bae ; Chung, Wook Sung ; Jang, Yang Soo ; Rha, Seung-Woon ; Bae, Jang Ho ; Park, Seung Jung. / Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease. In: Korean Journal of Internal Medicine. 2012 ; Vol. 27, No. 4. pp. 397-406.
@article{a287db5d32484eee88c0d8efc8d52172,
title = "Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease",
abstract = "Background/Aims: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI) patients with chronic kidney disease (CKD). Methods: This study included a total of 3,566 acute MI survivors with CKD from the Korea Acute Myocardial Infarction Registry who were treated with stenting and followed up for 12 months: 1,845 patients who received sirolimus-eluting stents (SES), 1,356 who received paclitaxel-eluting stents (PES), and 365 who received zotarolimus-eluting stents (ZES). CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m2 calculated by the modification of diet in renal disease method. Results: At the 12-month follow-up, patients receiving ZES demonstrated a higher incidence (14.8{\%}) of major adverse cardiac events (MACEs) compared to those receiving SES (10.1{\%}) and PES (12{\%}, p = 0.019). The ZES patients also had a higher incidence (3.9{\%}) of target lesion revascularization (TLR) compared to those receiving SES (1.5{\%}) and PES (2.4{\%}, p = 0.011). After adjusting for confounding factors, ZES was associated with a higher incidence of MACE and TLR than SES (adjusted hazard ratio [HR], 0.623; 95{\%} confidence interval [CI], 0.442 to 0.879; p = 0.007; adjusted HR, 0.350; 95{\%} CI, 0.165 to 0.743; p = 0.006, respectively), and with a higher rate of TLR than PES (adjusted HR, 0.471; 95{\%} CI, 0.223 to 0.997; p = 0.049). Conclusions: Our findings suggest that ZES is less effective than SES and PES in terms of 12-month TLR, and has a higher incidence of MACE due to a higher TLR rate compared with SES, in acute MI patients with CKD.",
keywords = "Chronic, Myocardial infarction, Renal insufficiency, Stents",
author = "Daisuke Hachinohe and Jeong, {Myung Ho} and Shigeru Saito and Kim, {Min Chol} and Cho, {Kyung Hoon} and Khurshid Ahmed and Hwang, {Seung Hwan} and Lee, {Min Goo} and Sim, {Doo Sun} and Park, {Keun Ho} and Kim, {Ju Han} and Hong, {Young Joon} and Youngkeun Ahn and Kang, {Jung Chaee} and Kim, {Jong Hyun} and Chae, {Shung Chull} and Kim, {Young Jo} and Hur, {Seung Ho} and Seong, {In Whan} and Hong, {Taek Jong} and Donghoon Choi and Cho, {Myeong Chan} and Kim, {Chong Jin} and Seung, {Ki Bae} and Chung, {Wook Sung} and Jang, {Yang Soo} and Seung-Woon Rha and Bae, {Jang Ho} and Park, {Seung Jung}",
year = "2012",
month = "12",
day = "1",
doi = "10.3904/kjim.2012.27.4.397",
language = "English",
volume = "27",
pages = "397--406",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "4",

}

TY - JOUR

T1 - Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease

AU - Hachinohe, Daisuke

AU - Jeong, Myung Ho

AU - Saito, Shigeru

AU - Kim, Min Chol

AU - Cho, Kyung Hoon

AU - Ahmed, Khurshid

AU - Hwang, Seung Hwan

AU - Lee, Min Goo

AU - Sim, Doo Sun

AU - Park, Keun Ho

AU - Kim, Ju Han

AU - Hong, Young Joon

AU - Ahn, Youngkeun

AU - Kang, Jung Chaee

AU - Kim, Jong Hyun

AU - Chae, Shung Chull

AU - Kim, Young Jo

AU - Hur, Seung Ho

AU - Seong, In Whan

AU - Hong, Taek Jong

AU - Choi, Donghoon

AU - Cho, Myeong Chan

AU - Kim, Chong Jin

AU - Seung, Ki Bae

AU - Chung, Wook Sung

AU - Jang, Yang Soo

AU - Rha, Seung-Woon

AU - Bae, Jang Ho

AU - Park, Seung Jung

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Background/Aims: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI) patients with chronic kidney disease (CKD). Methods: This study included a total of 3,566 acute MI survivors with CKD from the Korea Acute Myocardial Infarction Registry who were treated with stenting and followed up for 12 months: 1,845 patients who received sirolimus-eluting stents (SES), 1,356 who received paclitaxel-eluting stents (PES), and 365 who received zotarolimus-eluting stents (ZES). CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m2 calculated by the modification of diet in renal disease method. Results: At the 12-month follow-up, patients receiving ZES demonstrated a higher incidence (14.8%) of major adverse cardiac events (MACEs) compared to those receiving SES (10.1%) and PES (12%, p = 0.019). The ZES patients also had a higher incidence (3.9%) of target lesion revascularization (TLR) compared to those receiving SES (1.5%) and PES (2.4%, p = 0.011). After adjusting for confounding factors, ZES was associated with a higher incidence of MACE and TLR than SES (adjusted hazard ratio [HR], 0.623; 95% confidence interval [CI], 0.442 to 0.879; p = 0.007; adjusted HR, 0.350; 95% CI, 0.165 to 0.743; p = 0.006, respectively), and with a higher rate of TLR than PES (adjusted HR, 0.471; 95% CI, 0.223 to 0.997; p = 0.049). Conclusions: Our findings suggest that ZES is less effective than SES and PES in terms of 12-month TLR, and has a higher incidence of MACE due to a higher TLR rate compared with SES, in acute MI patients with CKD.

AB - Background/Aims: To determine which drug-eluting stents are more effective in acute myocardial infarction (MI) patients with chronic kidney disease (CKD). Methods: This study included a total of 3,566 acute MI survivors with CKD from the Korea Acute Myocardial Infarction Registry who were treated with stenting and followed up for 12 months: 1,845 patients who received sirolimus-eluting stents (SES), 1,356 who received paclitaxel-eluting stents (PES), and 365 who received zotarolimus-eluting stents (ZES). CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m2 calculated by the modification of diet in renal disease method. Results: At the 12-month follow-up, patients receiving ZES demonstrated a higher incidence (14.8%) of major adverse cardiac events (MACEs) compared to those receiving SES (10.1%) and PES (12%, p = 0.019). The ZES patients also had a higher incidence (3.9%) of target lesion revascularization (TLR) compared to those receiving SES (1.5%) and PES (2.4%, p = 0.011). After adjusting for confounding factors, ZES was associated with a higher incidence of MACE and TLR than SES (adjusted hazard ratio [HR], 0.623; 95% confidence interval [CI], 0.442 to 0.879; p = 0.007; adjusted HR, 0.350; 95% CI, 0.165 to 0.743; p = 0.006, respectively), and with a higher rate of TLR than PES (adjusted HR, 0.471; 95% CI, 0.223 to 0.997; p = 0.049). Conclusions: Our findings suggest that ZES is less effective than SES and PES in terms of 12-month TLR, and has a higher incidence of MACE due to a higher TLR rate compared with SES, in acute MI patients with CKD.

KW - Chronic

KW - Myocardial infarction

KW - Renal insufficiency

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=84871796114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871796114&partnerID=8YFLogxK

U2 - 10.3904/kjim.2012.27.4.397

DO - 10.3904/kjim.2012.27.4.397

M3 - Article

VL - 27

SP - 397

EP - 406

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 4

ER -